炎症性肠病
医学
炎症性肠病
疾病
克罗恩病
临床实习
发病机制
生物信息学
重症监护医学
纳米技术
克罗恩病
炎症反应
溃疡性结肠炎
免疫学
机制(生物学)
评论文章
疾病治疗
促炎细胞因子
信号通路
活性氧
作者
黄辰晔,Chenxi Xu,Manli Cui,Yifan Li,Zhan Zhang,Qian Li,Mingxin Zhang
摘要
Inflammatory bowel disease (IBD) is a chronic gastrointestinal disorder with a complex pathogenesis and limited therapeutic options. Nanozymes, particularly carbon dots (CDs), offer a novel strategy for treating IBD owing to their enzyme-like catalytic activities and high biocompatibility. Traditional Chinese medicine (TCM) involves the use of rich sources of bioactive compounds with anti-inflammatory and antioxidant properties; however, the clinical application of these compounds is often hampered by their low solubility and bioavailability. This review explored the effects of TCM-derived CD nanozymes (TCM-CDs) on enhancing IBD therapy. The classification, green synthesis methods, and unique mechanisms of TCM-CDs, including reactive oxygen species scavenging, regulation of gut microbiota, and modulation of inflammatory signaling pathways, were summarized. Furthermore, the current limitations in material synthesis, biological uncertainty, and clinical translation challenges were discussed; an AI-driven framework was developed for future precision design and personalized IBD treatment. TCM-CDs represent promising nanoplatforms that synergize the multitarget therapeutic advantages of TCM with the catalytic versatility of nanozymes, offering new insights into next-generation IBD therapeutics.
科研通智能强力驱动
Strongly Powered by AbleSci AI